The Senate has officially approved the pharmacare bill, a pivotal component of the political agreement between the Liberal and NDP parties. The legislation is now poised to become law after passing without any amendments.
This bill will pave the way for the development of a national, universal pharmacare plan, enabling the government to establish agreements with provinces and territories. This will facilitate the coverage of diabetes and birth control medications within Canada’s public health system.
The specifics of the bill were the result of careful negotiations as part of the now-canceled supply-and-confidence arrangement between the NDP and Liberals. Notably, British Columbia has already entered into a memorandum of understanding with Ottawa to initiate the program within the province.
Health Minister Mark Holland expressed optimism about expanding the program nationwide, aiming to have all provinces and territories participate by next spring. However, the bill must receive royal assent before any official agreements can be signed.
Related topics:
Study Sheds Light on Non-Diabetic Kidney Disease Factors in Diabetic Patients
Semaglutide Linked to Reduced Opioid Overdose Risk in Diabetic Patients
Increased Amputation Risk for Diabetics in Lower-Income Areas, Report Reveals
